I

Ina Research Inc
TSE:2176

Watchlist Manager
Ina Research Inc
TSE:2176
Watchlist
Price: 899 JPY 0.11% Market Closed
Market Cap: ¥2.7B

Operating Margin

11%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
11%
=
Operating Income
¥351.8m
/
Revenue
¥3.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
11%
=
Operating Income
¥351.8m
/
Revenue
¥3.2B

Peer Comparison

Country Company Market Cap Operating
Margin
JP
Ina Research Inc
TSE:2176
2.7B JPY
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
165.5B USD
Loading...
CH
Lonza Group AG
SIX:LONN
37.6B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.8B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Higher than 72% of companies in Japan
Percentile
72st
Based on 6 730 companies
72st percentile
11%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

Ina Research Inc
Glance View

Ina Research, Inc. engages in the development of pharmaceutical products. The company is headquartered in Ina-Shi, Nagano-Ken and currently employs 194 full-time employees. The company went IPO on 2008-06-25. The firm operates in two business segments. The Contract Test segment is engaged in the provision of non-clinical test services to confirm the safety and efficacy of developed pharmaceuticals and food materials based on laboratory animals and cells for pharmaceutical development companies, food-related companies, research institutes and others. The Environmental segment is engaged in the design and sale of animal facilities for pharmaceutical companies and universities, deodorant-loaded devices, sterilization equipment, equipment for laboratory animals and others.

Intrinsic Value
Not Available
I
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
11%
=
Operating Income
¥351.8m
/
Revenue
¥3.2B
How has Operating Margin changed over time?

Over the last 3 years, Ina Research Inc’s Operating Margin has increased from 3.6% to 11%. During this period, it reached a low of 1.3% on Jun 30, 2020 and a high of 11% on May 1, 2022.

Back to Top